Substance: lanreotide
Date of last drug list: 01-12-2022
Commercial code: W58561001
Concentration: 30mg
Pharmaceutical form: powder + solvent for suspension injection with prolonged release
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).